Potential benefit of angiotensin II in COVID-19 patients: beyond reasonable doubt?

Overview of attention for article published in Critical Care, June 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 128,444 followers.

RT @ISICEM: @ISICEM Covid-19 input: Potential benefit of angiotensin II in #COVIDー19 patients: beyond reasonable doubt? @jlvincen #wecarei…

Not everything is a good idea. https://t.co/XWnBBPxn1g

RT @OrlandoRPN: Y ya se andan peleando sobre si hay beneficio o no de usar Angiotensina II en #COVID-19... 🥴 https://t.co/E22APcvPRg https:…

RT @OrlandoRPN: Y ya se andan peleando sobre si hay beneficio o no de usar Angiotensina II en #COVID-19... 🥴 https://t.co/E22APcvPRg https:…

Y ya se andan peleando sobre si hay beneficio o no de usar Angiotensina II en #COVID-19... 🥴 https://t.co/E22APcvPRg https://t.co/mD57GxR099